Overview
Availability
- Associate Professor Simone M Goldinger is:
- Available for supervision
Qualifications
- Bachelor (Honours) of Medicine, University of Zurich
- Masters (Research) of Medicine and Surgery and Medical Science, University of Zurich
- Doctoral (Research), University of Zurich
- Professional Doctorate, University of Zurich
- Fellow, Australasian College of Dermatologists, Australasian College of Dermatologists
Works
Search Professor Simone M Goldinger’s works on UQ eSpace
2019
Journal Article
Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study
Drago, Joshua Z., Lawrence, Donald, Livingstone, Elisabeth, Zimmer, Lisa, Chen, Tianqi, Giobbie-Hurder, Anita, Amann, Valerie C., Mangana, Joanna, Siano, Marco, Zippelius, Alfred, Dummer, Reinhard, Goldinger, Simone M. and Sullivan, Ryan J. (2019). Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study. Melanoma Research, 29 (1), 65-69. doi: 10.1097/CMR.0000000000000527
2019
Journal Article
Peripheral blood TCR repertoire profiling may facilitate patient stratification for immunotherapy against melanoma
Hogan, Sabrina A., Courtier, Anais, Cheng, Phil F., Jaberg-Bentele, Nicoletta F., Goldinger, Simone M., Manuel, Manuarii, Perez, Solene, Plantier, Nadia, Mouret, Jean-Francois, Thi Dan Linh Nguyen-Kim,, Raaijmakers, Marieke I. G., Kvistborg, Pia, Pasqual, Nicolas, Haanen, John B. A. G., Dummer, Reinhard and Levesque, Mitchell P. (2019). Peripheral blood TCR repertoire profiling may facilitate patient stratification for immunotherapy against melanoma. Cancer Immunology Research, 7 (1), 77-85. doi: 10.1158/2326-6066.CIR-18-0136
2018
Journal Article
Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection
Tio, Martin, Rai, Rajat, Ezeoke, Ogochukwu M., McQuade, Jennifer L., Zimmer, Lisa, Khoo, Chloe, Park, John J., Spain, Lavinia, Turajlic, Samra, Ardolino, Luke, Yip, Desmond, Goldinger, Simone M., Cohen, Justine V., Millward, Michael, Atkinson, Victoria, Kane, Alisa Y., Ascierto, Paolo A., Garbe, Claus, Gutzmer, Ralf, Johnson, Douglas B., Rizvi, Hira A., Joshua, Anthony M., Hellmann, Matthew D., Long, Georgina V. and Menzies, Alexander M. (2018). Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection. European Journal of Cancer, 104, 137-144. doi: 10.1016/j.ejca.2018.09.017
2018
Journal Article
The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe
Dimitriou, Florentia, Krattinger, Regina, Ramelyte, Egle, Barysch, Marjam J., Micaletto, Sara, Dummer, Reinhard and Goldinger, Simone M. (2018). The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe. Current Oncology Reports, 20 (11) 87. doi: 10.1007/s11912-018-0732-8
2018
Journal Article
Phase I, open-label study of pasireotide in patients with <i>BRAF</i>-wild type and <i>NRAS</i>-wild type, unresectable and/or metastatic melanoma
Dummer, Reinhard, Michielin, Olivier, Nageli, Mirjam Chantal, Goldinger, Simone M., Campigotto, Federico, Kriemler-Krahn, Ulrike, Schmid, Herbert, Pedroncelli, Alberto, Micaletto, Sara and Schadendorf, Dirk (2018). Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma. Esmo Open, 3 (5) UNSP e000388. doi: 10.1136/esmoopen-2018-000388
2018
Journal Article
Sarcoid-like reactions in patients receiving modern melanoma treatment
Dimitriou, Florentia, Frauchiger, Anna L., Urosevic-Maiwald, Mirjana, Naegeli, Mirjam C., Goldinger, Simone M., Barysch, Marjam, Franzen, Daniel, Kamarachev, Jivko, Braun, Ralph, Dummer, Reinhard and Mangana, Joanna (2018). Sarcoid-like reactions in patients receiving modern melanoma treatment. Melanoma Research, 28 (3), 230-236. doi: 10.1097/CMR.0000000000000437
2018
Conference Publication
The utility of chemotherapy after immunotherapy failure in metastatic melanoma: A multicenter case series
Goldinger, Simone M., Lo, Serigne, Hassel, Jessica Cecile, Forschner, Andrea, McKean, Meredith Ann, Zimmer, Lisa, Khoo, Chloe Chia Hoey, Dummer, Reinhard, Eroglu, Zeynep, Buchbinder, Elizabeth Iannotti, Ascierto, Paolo Antonio, Gutzmer, Ralf, Rozeman, Elisa A., Hoeller, Christoph, Johnson, Douglas Buckner, Gesierich, Anja, Kolblinger, Peter, Benannoune, Naima, Cohen, Justine Vanessa and Menzies, Alexander M. (2018). The utility of chemotherapy after immunotherapy failure in metastatic melanoma: A multicenter case series. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2018.36.15_suppl.e21588
2018
Journal Article
Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study (vol 91, pg 116, 2018)
Valpione, Sara, Carlino, Matteo S., Mangana, Johanna, Mooradian, Meghan J., McArthur, Grant, Schadendorf, Dirk, Hauschild, Axel, Menzies, Alexander M., Arance, Ana, Ascierto, Paolo A., Di Giacomo, AnnaMaria, de Rosa, Francesco, Larkin, James, Park, John J., Goldinger, Simone M., Sullivan, Ryan J., Xu, Wen, Livingstone, Elisabeth, Weichenthal, Michael, Rai, Rajat, Gaba, Lydia, Long, Georgina V. and Lorigan, Paul (2018). Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study (vol 91, pg 116, 2018). European Journal of Cancer, 93, 158-158. doi: 10.1016/j.ejca.2018.02.001
2018
Journal Article
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients
Hecht, Markus, Meier, Friedegund, Zimmer, Lisa, Polat, Bulent, Loquai, Carmen, Weishaupt, Carsten, Forschner, Andrea, Gutzmer, Ralf, Utikal, Jochen S., Goldinger, Simone M., Geier, Michael, Hassel, Jessica C., Balermpas, Panagiotis, Kiecker, Felix, Rauschenberg, Ricarda, Dietrich, Ursula, Clemens, Patrick, Berking, Carola, Grabenbauer, Gerhard, Schadendorf, Dirk, Grabbe, Stephan, Schuler, Gerold, Fietkau, Rainer, Distel, Luitpold V. and Heinzerling, Lucie (2018). Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients. British Journal of Cancer, 118 (6), 785-792. doi: 10.1038/bjc.2017.489
2018
Journal Article
Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
Valpione, Sara, Carlino, Matteo S., Mangana, Johanna, Mooradian, Meghan J., McArthur, Grant, Schadendorf, Dirk, Hauschild, Axel, Menzies, Alexander M., Arance, Ana, Ascierto, Paolo A., Di Giacomo, AnnaMaria, de Rosa, Francesco, Larkin, James, Park, John J., Goldinger, Simone M., Sullivan, Ryan J., Xu, Wen, Livingstone, Elisabeth, Weichenthal, Michael, Rai, Rajat, Gaba, Lydia, Long, Georgina V. and Lorigan, Paul (2018). Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study. European Journal of Cancer, 91, 116-124. doi: 10.1016/j.ejca.2017.12.007
2018
Journal Article
A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma
Krahenbuhl, Lukas, Goldinger, Simone M., Mangana, Joanna, Kerl, Katrin, Chevolet, Ines, Brochez, Lieve, Horak, Christine, Levesque, Mitch, Dummer, Reinhard and Cheng, Phil F. (2018). A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma. Neoplasia, 20 (2), 218-225. doi: 10.1016/j.neo.2017.12.002
2017
Journal Article
Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanoma
Amann, V. C., Hoffmann, D., Mangana, J., Dummer, R. and Goldinger, S. M. (2017). Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanoma. Journal of the European Academy of Dermatology and Venereology, 31 (10), 1638-1640. doi: 10.1111/jdv.14268
2017
Journal Article
Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab
Brueggemann, C., Kirchberger, M. C., Goldinger, S. M., Weide, B., Konrad, A., Erdmann, M., Schadendorf, D., Croner, R. S., Krahenbuhl, L., Kaehler, K. C., Hafner, C., Leisgang, W., Kiesewetter, F., Dummer, R., Schuler, G., Stuerzl, M. and Heinzerling, L. (2017). Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab. Journal of Cancer Research and Clinical Oncology, 143 (10), 1977-1984. doi: 10.1007/s00432-017-2450-2
2017
Journal Article
Electrical Impedance Spectroscopy in Skin Cancer Diagnosis
Braun, Ralph P., Mangana, Johanna, Goldinger, Simone, French, Lars, Dummer, Reinhard and Marghoob, Ashfaq A. (2017). Electrical Impedance Spectroscopy in Skin Cancer Diagnosis. Dermatologic Clinics, 35 (4), 489-+. doi: 10.1016/j.det.2017.06.009
2017
Conference Publication
Immunotherapy in patients with concurrent solid organ transplant, HIV, and Hepatitis B and C
Rai, R., Ezeoke, O. M., McQuade, J. L., Zimmer, L., Koo, C., Park, J. J., Ardolino, L., Yip, D., Goldinger, S., Cohen, J. V., Millward, M., Atkinson, V., Kane, A. Y., Ascierto, P. A., Garbe, C., Gutzmer, R., Johnson, D. B., Hellman, M. D., Long, G. V. and Menzies, A. M. (2017). Immunotherapy in patients with concurrent solid organ transplant, HIV, and Hepatitis B and C. 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid Spain, Sep 08-12, 2017. OXFORD: OXFORD UNIV PRESS.
2017
Conference Publication
Melanoma patients treated with Encorafenib show less hyperproliferative keratinocytic cutaneous adverse events and more intense inflammatory palmoplantar erythrodysesthesia compared to other BRAF inhibitors
Graf, N., Goldinger, S., Galliker, N., Conrad, S. and Dummer, R. (2017). Melanoma patients treated with Encorafenib show less hyperproliferative keratinocytic cutaneous adverse events and more intense inflammatory palmoplantar erythrodysesthesia compared to other BRAF inhibitors. HOBOKEN: WILEY.
2017
Journal Article
Interstitial granulomatous dermatitis during talimogen laherparepvec treatment
Frauchiger, Anna L., Bruggen, Marie-Charlotte, Goldinger, Simone M. and Dummer, Reinhard (2017). Interstitial granulomatous dermatitis during talimogen laherparepvec treatment. Melanoma Research, 27 (4), 400-401. doi: 10.1097/CMR.0000000000000369
2017
Journal Article
Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report
Murer, Carla, Kranzlin-Stieger, Pascale, French, Lars E., Dummer, Reinhard and Goldinger, Simone M. (2017). Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report. Melanoma Research, 27 (4), 396-398. doi: 10.1097/CMR.0000000000000358
2017
Journal Article
Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland
Mangana, Joanna, Cheng, Phil F., Kaufmann, Corina, Amann, Valerie C., Frauchiger, Anna L., Stoegner, Viola, Held, Ulrike, von Moos, Roger, Michielin, Olivier, Braun, Ralph P., Levesque, Mitchell P., Goldinger, Simone M. and Dummer, Reinhard (2017). Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Melanoma Research, 27 (4), 358-368. doi: 10.1097/CMR.0000000000000359
2017
Journal Article
A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status
Izar, Benjamin, Sharfman, William, Hodi, F. Stephen, Lawrence, Donald, Flaherty, Keith T., Amaravadi, Ravi, Kim, Kevin B., Puzanov, Igor, Sosman, Jeffrey, Dummer, Reinhard, Goldinger, Simone M., Lam, Lyhping, Kakar, Shefali, Tang, Zhongwen, Krieter, Oliver, McDermott, David F. and Atkins, Michael B. (2017). A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status. Cancer Medicine, 6 (8), 1904-1914. doi: 10.1002/cam4.1140
Supervision
Availability
- Associate Professor Simone M Goldinger is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Associate Professor Simone M Goldinger's areas of expertise, story ideas and help finding experts, contact our Media team: